MedGenome is a genomic-driven diagnostics and research company.
Investment highlights
2013
Year of establishment
India
Country
2017
Year of entry
15.52%
Shareholding percentage *
Healthcare and life sciences
Sector
* Sofina has an observer seat in the decision-making bodies of the company.
With offices and labs in India, California and Singapore, the company MedGenome is the market leader for genetic diagnostics in South Asia and a worldwide leading provider of genomics research services. Its unique access to genomic, clinical and phenotypic data allows it to better understand complex diseases at the genetic and molecular level, and thereby to facilitate research into personalized healthcare.
Sofina invested in MedGenome in 2017. Other investors include Peak XV Partners, LeapFrog Investments and Novo Holdings.